MK6892

MK6892 is an experimental drug which acts as a potent and selective agonist for the Hydroxycarboxylic acid receptor 2 (GPR109A). It has been investigated for lowering blood lipid levels and potential applications in the treatment of colon cancer.
Wikipedia contributors, "MK6892", Wikipedia, revision 1368845427, retrieved 20 November 2026, source, CC BY-SA 4.0.